Trial Profile
A multiple-center, randomized, double-blind, placebo-controlled, parallel-group comparison study in idiopathic carpal tunnel syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2022
Price :
$35
*
At a glance
- Drugs Limaprost (Primary)
- Indications Carpal tunnel syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ono Pharmaceutical; Sumitomo Dainippon Pharma
- 25 May 2016 New trial record